// App-Quantinova.ai

1217-104 : THE GLOBAL REGISTRY PROGRAM ON LONG-TERM ORAL ANTI-THROMBOTIC TREATMENT IN PATIENTS WITH ATRIAL FIBRILLATION (GLORIA-AF): FIRST ASSESSMENT OF BASELINE CHARACTERISTICS OF DABIGATRAN AND VKA COHORTS IN NORTH AMERICA

Researchers

Presenter

  • Ken Rothman

Principal Investigators

  • Menno V. Huisman

  • Gregory Lip

  • Andreas Clemens

  • Hans-Christoph Diener

  • Sergio J. Dubner

  • Chang-Sheng Ma

  • Christine Teutsch

  • Kristina Zint

  • Nils Schoof

  • Miney Paquette

  • Eva Kleine

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Non-valvular atrial fibrillation

  • Venous thrombosis

  • Arrhythmia

  • Hypertension

  • Stroke

Biomarkers

  • Creatinine

Drug/Treatment

  • Pradax

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved